At ORCID we take our privacy and security seriously. As of April 9, 2014, all ORCID systems have been updated to protect against the "Heartbleed" vulnerability. As an extra precaution, recommends that you reset your password to something new and not utilized on any other website. Learn more here.

Nicola Simola

Keywords: Parkinson's disease, adenosine, caffeine, behavioural pharmacology, rat

Personal Information


Dr. Simola holds a M.S. in Pharmaceutical Chemistry and a Ph. D. in Pharmacology of Drug Dependence. Dr. Simola currently performs his research at the Department of Biomedical Sciences of the University of Cagliari, where he is Assistant Professor in Pharmacology. Dr. Simola’s research involves the study and development of new therapeutic agents for the treatment of Parkinson’s disease, focusing on adenosine receptor antagonists, the development of new preclinical models of early-stage Parkinson’s disease, and the study of the interactions between caffeine and other recreational psychostimulants.


  • {{work.publicationDate.year}}-{{work.publicationDate.month}}

No publications added yet